Solid phase extraction and LC-MS/MS quantification of ibandronate in human plasma

被引:0
|
作者
Moustapha, Moustapha E. [1 ,2 ]
Abdel-Gawad, Sherif A. [3 ,4 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Coll Sci & Humanities, Dept Chem, Ai Kharj 11942, Saudi Arabia
[2] Prince Sattam BinAbdulaziz Univ, Univ Cent Lab, Coll Sci & Humanities, Al Kharj 11942, Saudi Arabia
[3] Prince Sattam BinAbdulaziz Univ, Coll Pharm, Pharmaceut Chem Dept, Al Kharj, Saudi Arabia
[4] Cairo Univ, Fac Pharm, Analyt Chem Dept, Cairo, Egypt
关键词
Ibandronate; LC-MS/MS; Validation; Derivatization; Solid-phase extraction; ALENDRONATE;
D O I
10.4314/tjpr.v19i6.26
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To develop and validate a simple, highly sensitive and accurate method for the quantification of ibandronate (IBN) in human plasma. Methods: Electrospray ionization liquid chromatography tandem mass spectrometry (LC-MS/MS) in positive ion mode was applied to obtain optimum signals. The parent ion was acquired under collision-activated dissociation conditions, and the abundant fragments used to design multiple reaction monitoring experiments for monitoring two ibandronate transitions (m/z 376 to m/z 114, and m/z 376 to m/z 250). The IBN was isolated from plasma with weak anion exchange solid phase extraction columns with 'on-cartridge' derivatization using tri-methylsilyl-diazomethane (TMSDZ) reagent to convert IBN to tetra-methyl derivative. Results: The studied drug was successfully extracted from plasma samples without any interference at a retention time of 3.2 min. The matrix effect averaged 110 %, indicating that endogenous materials had little effect on ionization. The relationship between plasma analyte concentration and IBN signal area was satisfactorily linear, with correlation coefficient (r2) ranging from 0.9817 to 0.9942 in the concentration range of 0.5 - 200 ng/ml. The lower and upper limits of quantification (LLOQ and ULOQ) for IBN were 0.5 and 200 ng/ml, respectively. Relative recovery of IBN from plasma after extraction and derivatization at 3 distinct concentrations was 83.93 to 85.06 %, relative to standard solutions. The ranges of intra- and inter-day accuracies of quantification of quality controls were 89.39 - 106.40 %, and 90.50 - 107.96 %, respectively. Processed plasma IBN extracts were stable in autosampler at 4 0C (91.12 to 103.49%). Long-term stability in plasma after 30 days at -24 0C ranged from 89.52 to 113.18 %. Conclusion: This validated LC-MS/MS method can be successfully applied for determination of IBN in pharmacokinetic studies. It is a sensitive and specific assay for plasma IBN in bioequivalence studies.
引用
收藏
页码:1295 / 1302
页数:8
相关论文
共 50 条
  • [31] Quantification of isradipine in human plasma using LC-MS/MS for pharmacokinetic and bioequivalence study
    Park, Jin-Hee
    Park, Yoo-Sin
    Rhim, Si-Youn
    Jhee, Ok-Hwa
    Lim, Shin-Hee
    Yang, Seok-Chul
    Lee, Min-Ho
    Shaw, Leslie M.
    Kang, Ju-Seop
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (1-2): : 59 - 64
  • [32] Quantification of pseudoephedrine in human plasma by LC-MS/MS using mosapride as internal standard
    Nirogi, Ramakrishna V. S.
    Kandikere, Vishwottam N.
    Shukla, Manoj
    Mudigonda, Koteshwara
    Maurya, Santosh
    Komarneni, Prashanth
    BIOMEDICAL CHROMATOGRAPHY, 2007, 21 (03) : 241 - 248
  • [33] A Simple LC-MS/MS Method for the Quantification of PDA-66 in Human Plasma
    Schwarz, Rico
    Seiler, Elisabeth R. D.
    Sender, Sina
    Pews-Davtyan, Anahit
    Murua Escobar, Hugo
    Zechner, Dietmar
    Beller, Matthias
    Junghanss, Christian
    Hinz, Burkhard
    MOLECULES, 2022, 27 (03):
  • [34] A Streamlined Method for Quantification of Apolipoprotein A1 in Human Plasma by LC-MS/MS
    Shi, Junyan
    Zheng, Yu Zi
    Sin, Don D.
    DeMarco, Mari L.
    CLINICAL CHEMISTRY, 2018, 64 (12) : 1782 - 1784
  • [35] Quantification of pantoprazole in human plasma using LC-MS/MS for pharmacokinetics and bioequivalence study
    Li, Yun
    Ding, Mei-Juan
    Ma, Jing
    Wang, Shu
    Wu, Xiao-Li
    Xu, Hui-Juan
    Lu, Zheng-Yu
    Zou, Jian-Jun
    Fan, Hong-Wei
    Zhou, Xue-Min
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2011, 35 (3-4) : 147 - 155
  • [36] Novel LC-MS/MS method for the quantification of silodosin and its metabolites in human plasma
    Shah, Priyanka A.
    Shrivastav, Pranav S.
    BIOANALYSIS, 2018, 10 (01) : 7 - 10
  • [37] Fast and Straightforward Method for the Quantification of Pazopanib in Human Plasma Using LC-MS/MS
    Verheijen, Remy B.
    Thijssen, Bas
    Rosing, Hilde
    Schellens, Jan H. M.
    Nan, Lianda
    Venekamp, Nikkie
    Beijnen, Jos H.
    Steeghs, Neeltje
    Huitema, Alwin D. R.
    THERAPEUTIC DRUG MONITORING, 2018, 40 (02) : 230 - 236
  • [38] Quantification of Glycyrrhetic Acid in Human Plasma by LC-MS/MS: Application to a Pharmacokinetic Study
    Jing, Zhang
    Sui Qiangjun
    Chen, Wang
    CURRENT PHARMACEUTICAL ANALYSIS, 2017, 13 (04) : 334 - 339
  • [39] Development and validation of a LC-MS/MS method for the quantification of the regioisomers of dihydroxybutylether in human plasma
    Yuan, Bo
    Li, Li
    Fu, Yao
    Jin, Yi
    Guo, Lixin
    Xu, Haiyan
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 911 : 27 - 33
  • [40] Development of an LC-MS/MS method for the simultaneous quantification of aripiprazole and dehydroaripiprazole in human plasma
    Song, Min
    Xu, Xinxin
    Hang, Taijun
    Wen, Aidong
    Yang, Lin
    ANALYTICAL BIOCHEMISTRY, 2009, 385 (02) : 270 - 277